Do "Incidental Melanomas" Exist? If so, how many are they? High Time to Decide

• Giovanni Luigi Capella

  Dermatology & STD, Milan, Italy

Do "Clinically Insignificant, HIstological MElanoma-Like Lesions" (CIHIMELL) - to wit, merely incidental, looking-like-melanoma lesions devoid of intrinsic malignant potential - exist? The question arises from the fact that, in spite of increased diagnoses of completely excised malignant melanoma (MM) in the last two decades, mortality from advanced metastatic disease has not decreased. After a brief review of the literature, the author proposes that the existence of CIHIMELL could be affirmed through post mortem dermoscopy and histological study of any pigmented lesion, clinically or dermoscopically suspected, of several deceased patients undergoing necropsy for death causes unrelated to MM. Should the cumulative prevalence of merely histological melanomas turn out to be exceedingly high and not commensurable with the current death rates of true MM, the discrepancy would tangibly prove that indolent pigmented lesions with morphological aspect of melanoma do exist. This would clearly introduce difficulties that could satisfactorily be dealt with only through a paradigm shift in melanoma surveillance and diagnosis (which could also allow to add a piece of encouraging uncertainty to the patient-physician relationship). However, it can be expected that such an enterprise would be countered by several vested academic and commercial interests.

Swerlick RA, Chen S. The melanoma epidemic. Is increased surveillance the solution or the problem? Arch Dermatol 1996; 132: 881-4. https://doi.org/10.1001/archderm.132.8.881

Dennis LK. Analysis of the melanoma epidemic, both apparent and real. Data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol 1999; 135: 275-80. https://doi.org/10.1001/archderm.135.3.275

Lipsker D, Engel F, Cribier B, Velten M, Hedelin G. Trends in melanoma epidemiology suggest three different types of melanoma. Br J Dermatol 2007; 157: 338-43. https://doi.org/10.1111/j.1365-2133.2007.08029.x

Weyers W. The “epidemic” of melanoma between under- and overdiagnosis. J Cutan Pathol 2012; 39: 9-16. https://doi.org/10.1111/j.1600-0560.2011.01831.x

Levell NJ, Beattie CC, Shuster S, Greenberg DC. Melanoma epidemic: a midsummer night's dream? Br J Dermatol 2009; 161: 630-4. https://doi.org/10.1111/j.1365-2133.2009.09299.x

Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010; 102: 605-13. https://doi.org/10.1093/jnci/djq099

Boccon-Gibod L. Editorial: significant versus insignificant prostate cancer  can we identify the tigers from the pussy cats? J Urol 1996; 156: 1069-70. https://doi.org/10.1016/S0022-5347(01)65704-5

Glusac EJ. The melanoma “epidemic”: lessons from prostate cancer. J Cutan Pathol 2011; 39: 17-20. https://doi.org/10.1111/j.1600-0560.2011.01848.x

Liu W, Dowling JP, Murray WK, McArthur GA, Thompson JF, Wolfe R, Kelly JW. Rate of growth in melanomas. Characteristics and associations of rapidly growing melanomas. Arch Dermatol 2006; 142: 1551-8. https://doi.org/10.1001/archderm.142.12.1551

Demierre MF, Chung C, Miller DR, Geller AC. Early detection of thick melanomas in the United States. Beware of the nodular subtype. Arch Dermatol 2005; 141: 745-50. https://doi.org/10.1001/archderm.141.6.745

Lipsker D. Growth rate, early detection, and prevention of melanoma. Melanoma epidemiology revisited and future challenges. Arch Dermatol 2006; 142: 1638-40. https://doi.org/10.1001/archderm.142.12.1638

Argenziano G, Zalaudek I. Do we detect a new spectrum of biologically benign melanomas in the dermoscopy era? Expert Rev Dermatol 2006; 1: 361-7. https://doi.org/10.1586/17469872.1.3.361

Cerroni L, Barnhill R, Elder D, Gottlieb G, Heenan P, et al. Melanocytic tumors of uncertain malignant potential. Results of a tutorial held at the XXIX symposium of the International Society of Dermatopathology in Graz, October 2008. Am J Surg Pathol 2010; 34: 314-26. https://doi.org/10.1097/PAS.0b013e3181cf7fa0

Monk BE, Clement MI, Pembroke AC, DuVivier A. The incidental malignant melanoma. BMJ 1983; 287: 485-6. https://doi.org/10.1136/bmj.287.6390.485

Brod C, Schippert W, Breuninger H. Ausgeprägtes dysplastisches Nävussyndrom mit Entwicklung multipler Melanome. Operatives Konzept zur Prophylaxe. J Dtsch Dermatol Ges 2009; 7: 773-5. https://doi.org/10.1111/j.1610-0387.2009.07095_supp.x

McCalmont TH. In my opinion. J Cutan Pathol 2011; 38: 268. https://doi.org/10.1111/j.1600-0560.2010.01661.x

Foucar E. Debating melanocytic tumors of the skin: does an «uncertain diagnosis» signify borderline diagnostic skill? Am J Dermatopathol 1995; 17: 626-34. https://doi.org/10.1097/00000372-199512000-00020

Abaffy T, Duncan R, Riemer DD, Tietje O, Elgart G, et al. Differential volatile signatures from the skin, naevi and melanoma: a novel approach to detect a pathological process. PloS One 2010; 5: e13813. https://doi.org/10.1371/journal.pone.0013813

Argenziano G, Zalaudek I, Ferrara G, Johr R, Langford D, et al. Dermoscopy features of melanoma incognito: indications for biopsy. J Am Acad Derrmatol 2007; 56: 508-13. https://doi.org/10.1016/j.jaad.2006.10.029

Capella GL. Systematic video dermatoscopy search for melanoma incognito: a call for quantitative specifications. J Am Acad Dermatol 2008; 59: 533. https://doi.org/10.1016/j.jaad.2008.04.035

• PDF